A systematic development process for patient decision aids

检查表 决策辅助工具 过程(计算) 文档 计算机科学 健康信息学 医学 相关性(法律) 过程管理 范围(计算机科学) 质量(理念) 管理科学 医学物理学 心理学 护理部 替代医学 工程类 病理 公共卫生 认知心理学 政治学 法学 程序设计语言 哲学 操作系统 认识论
作者
Angela Coulter,Diana Stilwell,Jennifer Kryworuchko,Patricia Dolan Mullen,Chirk Jenn Ng,Trudy van der Weijden
出处
期刊:BMC Medical Informatics and Decision Making [Springer Nature]
卷期号:13 (S2) 被引量:502
标识
DOI:10.1186/1472-6947-13-s2-s2
摘要

The original version of the International Patient Decision Aid Standards (IPDAS) recommended that patient decision aids (PtDAs) should be carefully developed, user-tested and open to scrutiny, with a well-documented and systematically applied development process. We carried out a review to check the relevance and scope of this quality dimension and, if necessary, to update it.Our review drew on three sources: a) published papers describing PtDAs evaluated in randomised controlled trials and included in the most recent Cochrane Collaboration review; b) linked papers cited in the trial reports that described how the PtDAs had been developed; and c) papers and web reports outlining the development process used by organisations experienced in developing multiple PtDAs. We then developed an extended model of the development process indicating the various steps on which documentation is required, as well as a checklist to assess the frequency with which each of the elements was publicly reported.Key features common to all patient decision aid (PtDA) development processes include: scoping and design; development of a prototype; 'alpha' testing with patients and clinicians in an iterative process; 'beta' testing in 'real life' conditions (field tests); and production of a final version for use and/or further evaluation. Only about half of the published reports on the development of PtDAs that we reviewed appear to have been field tested with patients, and even fewer had been reviewed or tested by clinicians not involved in the development process. Very few described a distribution strategy, and surprisingly few (17%) described a method for reviewing and synthesizing the clinical evidence. We describe a model development process that includes all the original elements of the original IPDAS criterion, expanded to include consideration of format and distribution plans as well as prototype development.The case for including each of the elements outlined in our model development process is pragmatic rather than evidence-based. Optimal methods for ensuring that each stage of the process is carried out effectively require further development and testing.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
llt发布了新的文献求助10
刚刚
ddx完成签到,获得积分10
1秒前
追尾的猫完成签到 ,获得积分10
2秒前
量子星尘发布了新的文献求助10
2秒前
滕滕发布了新的文献求助10
3秒前
3秒前
会科研的胡萝卜完成签到,获得积分10
3秒前
3秒前
5秒前
顾矜应助粥粥采纳,获得10
5秒前
小鱼完成签到 ,获得积分10
6秒前
小伊001完成签到,获得积分10
6秒前
chengzhiheng完成签到,获得积分10
6秒前
7秒前
弗洛莉娅完成签到,获得积分10
8秒前
完美世界应助宁天问采纳,获得10
8秒前
Jasper应助lasak采纳,获得10
8秒前
chengzhiheng发布了新的文献求助10
8秒前
呵呵完成签到 ,获得积分10
9秒前
哈哈哈完成签到,获得积分10
9秒前
独特南霜发布了新的文献求助10
10秒前
虚荣的泥猴桃完成签到 ,获得积分10
10秒前
孙伟健发布了新的文献求助10
11秒前
深情安青应助Dopamine采纳,获得10
11秒前
da发布了新的文献求助10
11秒前
12秒前
lxy完成签到,获得积分10
13秒前
14秒前
华仔应助hh采纳,获得10
14秒前
学勾巴发布了新的文献求助10
14秒前
凤爪关注了科研通微信公众号
15秒前
天天快乐应助dayrim采纳,获得10
15秒前
16秒前
16秒前
烟花应助ellarqwn采纳,获得10
17秒前
rcf完成签到,获得积分10
17秒前
18秒前
xxfsx应助任侠传采纳,获得10
19秒前
量子星尘发布了新的文献求助10
19秒前
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Social Work Ethics Casebook: Cases and Commentary (revised 2nd ed.).. Frederic G. Reamer 1070
Alloy Phase Diagrams 1000
Introduction to Early Childhood Education 1000
2025-2031年中国兽用抗生素行业发展深度调研与未来趋势报告 1000
List of 1,091 Public Pension Profiles by Region 891
Historical Dictionary of British Intelligence (2014 / 2nd EDITION!) 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5424595
求助须知:如何正确求助?哪些是违规求助? 4538935
关于积分的说明 14164426
捐赠科研通 4455911
什么是DOI,文献DOI怎么找? 2443990
邀请新用户注册赠送积分活动 1435069
关于科研通互助平台的介绍 1412452